Hostname: page-component-76fb5796d-vfjqv Total loading time: 0 Render date: 2024-04-26T09:12:50.392Z Has data issue: false hasContentIssue false
  • English
  • Français

Dialysis care, cardiovascular disease, and costs in end-stage renal disease in Brazil

Published online by Cambridge University Press:  18 January 2007

Ricardo Sesso ,
Camilla Barbosa da Silva ,
Sérgio C. Kowalski ,
Silvia R. Manfredi ,
Maria E. Canziani ,
Sergio A. Draibe ,
Heba A. Elgazzar  and
Marcos B. Ferraz
Ricardo Sesso
Affiliation:
Federal University of São Paulo
Camilla Barbosa da Silva
Affiliation:
Federal University of São Paulo
Sérgio C. Kowalski
Affiliation:
Federal University of São Paulo
Silvia R. Manfredi
Affiliation:
Federal University of São Paulo
Maria E. Canziani
Affiliation:
Federal University of São Paulo
Sergio A. Draibe
Affiliation:
Federal University of São Paulo
Heba A. Elgazzar
Affiliation:
Genzyme Corporation
Marcos B. Ferraz
Affiliation:
Federal University of São Paulo
Get access Rights & Permissions [Opens in a new window]

Abstract

Objectives: This study evaluates the cost of dialysis care in Brazil, including costs of ambulatory care and hospital admissions due to all causes and cardiovascular events.

Methods: Data were analyzed for 200 patients with end-stage renal disease (ESRD) on chronic hemodialysis in Brazil between 2001 and 2004. Main end points were all-cause mortality, all-cause hospital admissions, and cardiovascular events. Direct costs of dialysis treatment and complications were computed from the perspective of two payers, the Ministry of Health (MoH) and private health insurance (PHI).

Results: Mean number of days of hospitalization was 12 per patient-year. There were 105 cardiovascular events; the most frequent events were coronary disease (n = 59, 56 percent) and congestive heart failure (n = 26, 25 percent). The rate of cardiovascular events was 193 per 1,000 patient-years. There were 43 deaths, and the death rate was 79 per 1,000 patient-years. Median cost per hospital admission was US$ 675 and US$ 932 from the perspective of the MoH and PHI. For admissions due to cardiovascular causes, the corresponding costs were US$ 1,639 and US$ 4,499, respectively. Mean global cost per patient-year for chronic hemodialysis therapy was US$ 7,980 and US$ 13,428 from the perspective of the MoH and PHI, respectively.

Conclusions: Patients on chronic hemodialysis care incur significant healthcare resources due to the costs of dialysis and complications, notably cardiovascular disease. New disease management programs aimed at reducing cardiovascular morbidity and efficient use of resources are critical to ensuring the sustainability of treatments for ESRD in Brazil.

Keywords

CostsDialysisEconomicsEnd-stage renal diseaseHemodialysis
Type
RESEARCH REPORTS
Information
International Journal of Technology Assessment in Health Care , Volume 23 , Issue 1 , January 2007 , pp. 126 - 130
Copyright
© 2007 Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Censo da SBN Jan/2005. Available at: http://www.sbn.org.br/. Assessed February, 2006.
Foley RN, Murray AM, Li S, et al. 2005 Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J Am Soc Nephrol. 16: 489– 495.Google Scholar
Gonzalez-Perez JG, Vale L, Stearns SC, Wordsworth S. 2005 Hemodialysis for end-stage renal disease: A cost-effectiveness analysis of treatment-options. Int J Technol Assess Health Care. 21: 32– 39.Google Scholar
Kirby L, Vale L. 2001 Dialysis for end-stage renal disease. Determining a cost-effective approach. Int J Technol Assess Health Care. 17: 181– 189.Google Scholar
Kroeker A, Clark WF, Heidenheim AP, et al. 2003 An operating cost comparison between conventional and home quotidian hemodialysis. Am J Kidney Dis. 42 (Suppl 1): 49– 55.Google Scholar
Lee H, Manns B, Taub K, et al. 2002 Cost analysis of ongoing care of patients with end-stage renal disease: The impact of dialysis modality and dialysis access. Am J Kidney Dis. 40: 611– 622.Google Scholar
McFarlane PA. 2004 Reducing hemodialysis costs: Conventional and quotidian home hemodialysis in Canada. Semin Dial. 17: 118– 124.Google Scholar
Ploth DW, Sheep PH, Counts C, Hutchinson F. 2003 Prospective analysis of global costs for maintenance of patients with ESRD. Am J Kidney Dis. 42: 12– 21.Google Scholar
Revista ABCFARMA (Associação Brasileira do Comércio Farmacêutico), Março 2005 (ano 12 N° 151 vol 1).
Schmidt RJ, Domico JR, Sorkin MI, Hobbs G. 1998 Early referral and its impact on emergent first dialysis, heath care costs, and outcomes. Am J Kidney Dis. 32: 278– 283.Google Scholar
Sesso R, Eisenberg JM, Stabile C, et al. 1990 Cost-effectiveness analysis of the treatment of end-stage renal disease in Brazil. Int J Technol Assess Health Care. 6: 107– 114.Google Scholar
Sesso R, Belasco AG. 1996 Late diagnosis of chronic renal failure and mortality on maintenance dialysis. Nephrol Dial Transplant. 11: 2417– 2420.Google Scholar
Shih YC, Guo A, Just PM, Mujais S. 2005 Impact of initial dialysis modality and modality switches on Medicare expenditures of end-stage renal disease patients. Kidney Int. 68: 319– 329.Google Scholar
St. Peter WL, Khan SS, Ebben JP, Pereira BJ, Collins AJ. 2004 Chronic kidney disease: The distribution of health care dollars. Kidney Int. 66: 313– 321.Google Scholar
Tabela de procedimentos de SIA/SIH-SUS. Available at: http://dtr2001.saude.gov.br/sas/Decas/tabelasia.sih.htm. Assessed September, 2005.
U.S. Renal Data System. 2005. 2005 USRDS annual data report. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases
Winkelmayer WC, Weinstein MC, Mittleman MA, Glynn RJ, Pliskin JS. 2002 Health economic evaluations: The special case of end-stage renal disease treatment. Med Decis Making. 22: 417– 430.Google Scholar